Hydroxyl purine compounds and applications thereof
USRE49128E1 · kind E1 · reissue
0Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2020 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Feb 19, 2040 |
Classification
- Technology area (CPC —)General
Abstract
Hydroxyl purine compounds represented by formula (I), tautomers or pharmaceutically acceptable salts thereof, and applications thereof as PDE2 or TNF-α inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.